Serum-Free Immunocompetent Cell Culture Using Boric Acid
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cell culture methods for producing immunocompetent cells, particularly for CAR-T cell therapy, rely on serum-containing media, which pose risks of infection and variation due to xenogeneic components, and are costly and time-consuming, with cells like iPS cell-derived CAR-T cells being vulnerable to washing stress.
Innovation Solution
Culturing cells in a serum-free or low-serum medium supplemented with boric acid or its salts, optionally with taurine, to maintain and promote cell proliferation, particularly for immunocompetent cells such as dendritic cells, B cells, and T cells, derived from pluripotent stem cells like iPS cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If serum-containing medium is used for cell culture, then cell proliferation is maintained, but risk of infection and variation increases due to xenogeneic components
Solution Approach 1:
The patent changes the chemical composition parameters of the culture medium by replacing serum components with specifically defined chemicals including boric acid (0.1-1.0 mM), taurine (0.1-10.0 mM), and various growth factors. This chemically defined composition maintains cell proliferation while eliminating xenogeneic components, resolving the contradiction between safety and productivity
Solution Approach 2:
The patent introduces boric acid and taurine as intermediary substances that mediate cell proliferation in the absence of serum. These compounds act as key mediators that replace the proliferative signals normally provided by serum, enabling serum-free culture while maintaining cell growth
2Reliability
If serum-free medium is used to eliminate xenogeneic components, then safety improves, but cell proliferation may be insufficient
Solution Approach 1:
The patent creates a composite chemically defined medium containing multiple specific components: boric acid, taurine, insulin, transferrin, selenium, and various growth factors. This composite formulation synergistically supports cell proliferation in serum-free conditions, maintaining safety while ensuring adequate productivity
Solution Approach 2:
The patent optimizes concentration parameters of each component in the serum-free medium, specifically setting boric acid at 0.1-1.0 mM and taurine at 0.1-10.0 mM. These parameter adjustments ensure optimal cell proliferation while maintaining the serum-free, xeno-free status of the medium
3Reliability
If extensive washing is performed to remove serum components, then purity improves, but cell damage increases due to washing stress
Solution Approach 1:
The patent extracts and eliminates the need for extensive washing steps by using a chemically defined medium from the outset. Since the medium contains no serum components requiring removal, cells can be cultured and harvested with minimal washing, thereby maintaining purity while reducing washing stress and cell damage
4Reliability
If multiple culture steps and viral vector preparation are used for autologous CAR-T therapy, then therapeutic effectiveness improves, but manufacturing cost and time increase
Solution Approach 1:
The patent enables allogeneic CAR-T cell production using universal donor cells that can be cultured and differentiated without requiring patient-specific viral vector preparation. This self-service approach eliminates multiple manufacturing steps, significantly reducing time and cost while maintaining therapeutic effectiveness through the use of standardized, pre-characterized cell lines
Data Source
AI summary
The present invention aims to provide a method that makes it possible to sufficiently proliferate cells, particularly immunocompetent cells, even in a serum-free medium or low-serum medium, and a medium additive and a medium composition to be used for the method. An effect of maintaining and promoting cell proliferation comparable to that achieved by culture in a serum-containing medium can be obtained even in a serum-free medium or a low-serum medium, by containing boric acid or a salt thereof.